Amprion Newsroom
Recent media coverage and announcements.
Press Release
PR Newswire
Michael J. Fox Foundation Funds Projects to Speed Development of Quantitative Biomarkers for Parkinson's Disease
May 30, 2024
Read MorePress Release
Business Wire
Amprion Unveils Next-Generation SAAmplify™ Biomarker Panels to Aid in Diagnosis of Neurodegenerative Disorders at AAIC 2024
July 26, 2024
Read MorePress Release
PR Newswire
Amprion Showcases SYNTap® Biomarker Test at AD/PD™ 2023 International Conference
March 27, 2023
Read MorePress Release
PR Newswire
Amprion Joins the Fight Against Parkinson's Through Early Detection Testing
May 23, 2019
Read MorePress Release
PR Web
Amprion Exhibits at MDS International Congress of Parkinson's Disease and Movement Disorders in Madrid and Presents Scientific Insights On SYNTap® Test at Prion2022 Conference
September 15, 2022
Read MorePress Release
PR Web
Amprion Clinical Laboratory Receives Accreditation from College of American Pathologists
October 27, 2021
Read MorePress Release
PR Web
Amprion Awarded NIH Grant For Analytical Validation of SYNTap® Biomarker Test For Neurological Disease
May 10, 2022
Read MorePress Release
PR Web
Amprion announces SYNTap™ Biomarker Test for early detection of Parkinson's Disease (PD) Lewy Body Dementia (LBD) and Alzheimer's Disease (AD)
October 6, 2021
Read MorePress Release
PR Newswire
Amprion Announces Presentation of Findings Related to Usage of the αSynuclein Seed Amplification Assay in Recent Parkinson's Study at 2023 AAN Annual Meeting
April 21, 2023
Read MorePress Release
PR Newswire
Amprion Announces Granting of European Patents for Seed Amplification Assay Platform
August 15, 2023
Read MorePress Release
Business Wire
Amprion Announces Initial Close of a $15M Financing to Commercialize Groundbreaking Neurologic Diagnostics
October 9, 2024
Read MorePress Release
PR Newswire
Amprion Announces Collaboration with NIH Researchers on Dementia Hallmark Study
August 23, 2023
Read MorePress Release
PR Newswire
ALS Network Announces $100000 Research Grant Awarded to Amprion Inc.
September 12, 2024
Read MorePodcast
Neurology Live
Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test (Episode 132)
January 10, 2025
Read MorePodcast
Clinical Lab Chaat
Alpha-Synuclein: Adding Precision to Neurodegenerative Testing
January 6, 2025
Read More
Get in the Know
Bring biological certainty to your diagnosis with Amprion's SAAmplify-É‘SYN test. Order your shipping kits today and help move your patient beyond a probable diagnosis.
